Efavirenz Medications

Efavirenz Info

What Is Efavirenz?

Efavirenz is an antiretroviral medicine that belongs to the non-nucleoside reverse transcriptase inhibitor (NNRTI) class. It works as part of combination therapy to keep the human immunodeficiency virus (HIV) from multiplying. In the UK, efavirenz is found in products such as Sustiva and in medicines that are simply marketed under the generic name Efavirenz.

Medications That Contain Efavirenz

In the United Kingdom, the most widely recognised brand that contains efavirenz is Sustiva, a tablet taken by mouth. The same active ingredient is also available as a generic product labelled Efavirenz. Both formulations come in tablets of 200 mg and 600 mg strength, allowing clinicians to tailor the total daily dose to the needs of each individual. While Sustiva is the original branded version, generic efavirenz tablets are produced by several licensed manufacturers and are widely dispensed through community pharmacies and specialist HIV clinics.

Conditions Treated with Efavirenz

• HIV-1 infection - Efavirenz is used together with other antiretroviral agents to treat adults and adolescents with HIV-1. The combination helps suppress the virus, maintain immune function and reduce the risk of illness.
• Pre-exposure prophylaxis (PrEP) regimens - In some treatment plans, efavirenz may form part of a preventive strategy for people at high risk of acquiring HIV, though this is less common than other agents.
• Therapeutic switch strategies - Patients who need to change from one antiretroviral regimen to another may be switched to an efavirenz-based combination when it offers a better balance of effectiveness and tolerability for them.

These uses are authorised by the Medicines and Healthcare products Regulatory Agency (MHRA) and are supported by clinical guidelines that recommend efavirenz as a key component of first-line therapy in many settings.

How Efavirenz Works

Efavirenz blocks a viral enzyme called reverse transcriptase, which HIV needs to copy its genetic material inside human cells. By stopping this step, the drug prevents new virus particles from being produced. The effect is seen within a few days of starting treatment, but a full reduction in viral load usually takes several weeks as the immune system recovers.

Safety and Side Effects

Common Side Effects

People taking efavirenz often notice mild effects that settle with continued use. Typical experiences include:

• Dizziness or a sensation of “heads-up” that can occur shortly after a dose.
• Trouble sleeping or vivid dreams, which may improve after the first few weeks.
• Nausea, mild stomach upset or loss of appetite.
• Skin rash that is usually mild and short-lived.

These symptoms are usually not serious and do not require stopping the medication, but they can be uncomfortable.

Serious Reactions

Rare but important warnings include:

• Severe allergic reactions, such as swelling of the face, lips, tongue or throat, or difficulty breathing.
• Signs of liver trouble, like yellowing of the skin or eyes, dark urine, or persistent nausea and abdominal pain.
• Unexplained fever, rash that spreads quickly, or blistering skin conditions.

If any of these occur, seek emergency medical attention promptly.

Who Should Be Cautious

Efavirenz is not recommended for people with a known hypersensitivity to the drug or any of its ingredients. It should be used with particular care in:

• Pregnant individuals, because efavirenz can affect fetal development during the first trimester.
• Patients with a history of severe psychiatric illness, as efavirenz may intensify symptoms such as depression or anxiety.
• Those with significant liver disease, since the liver processes the medication.

A thorough medical history helps determine whether efavirenz is suitable.

Interaction Awareness

Efavirenz can influence, or be influenced by, other medicines and substances. Important points include:

• Anticonvulsants (e.g., carbamazepine, phenytoin) may lower efavirenz levels, reducing its effectiveness.
• Rifampicin and other strong enzyme-inducing drugs can have a similar effect.
• Alcohol may increase dizziness and affect sleep, so moderation is advisable.
• Certain herbal products, such as St John’s wort, can also reduce efavirenz concentrations.

For a complete list of interactions, refer to the specific product information for Sustiva or the generic efavirenz tablet you are using.

Important Considerations

• Store tablets at room temperature, away from moisture and direct sunlight.
• Efavirenz is typically prescribed for long-term use, but the exact duration depends on the overall HIV treatment plan.
• Always read the patient leaflet that comes with your medication, as formulation-specific instructions (for example, taking the tablet with food) may differ.
• For detailed usage, dosing, and administration, refer to the information supplied with your particular medication.

Glossary

Non-nucleoside reverse transcriptase inhibitor (NNRTI): A class of drugs that block a key enzyme HIV needs to reproduce, without resembling the normal building blocks of DNA.

Viral load: The amount of HIV present in the blood, measured by laboratory tests.

Information Disclaimer

This article offers general educational information about efavirenz as an active substance used in various medicines. Its purpose is to help patients better understand the ingredient and the conditions it is used to treat. It is not a substitute for professional medical advice or for the specific instructions provided with individual products. Medicines containing efavirenz may differ in formulation, strength, and directions for use. Always consult the labeling of your particular medication and follow your healthcare provider’s guidance for complete information on proper use, dosage, and safety.